Ensysce Biosciences (ENSC) Non Operating Income (2020 - 2026)
Ensysce Biosciences (ENSC) recorded Non Operating Income of $11,967 in Q3 2025, down 29.7% from $17,023 a year earlier and down 29.6% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Non Operating Income (2020 - 2026) Analysis & Trends
On a TTM basis, Ensysce Biosciences' Non Operating Income came in at $62,958 as of Sep 30, 2025; for FY2024, it was -$1.26 million.
- Across earlier years, Non Operating Income came in at $91,912 in FY2023 (+537.8%), $14,410 in FY2022, -$9.28 million in FY2021 and $1.45 million in FY2020.
- The Q3 2025 figure is the lowest quarterly Non Operating Income since Q2 2024.
- Per Business Quant, the preceding three quarters came in at $16,998 (Q2 2025), $21,939 (Q1 2025) and $12,054 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Ensysce Biosciences | 4.69 Mn | -3.04 Mn | - | 5,514.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5,514.00 |
| Mar 31, 2026 | 5,815.00 |
| Dec 31, 2025 | 13,856.00 |
| Sep 30, 2025 | 11,967.00 |
| Jun 30, 2025 | 16,998.00 |
| Mar 31, 2025 | 21,939.00 |
| Dec 31, 2024 | 12,054.00 |
| Sep 30, 2024 | 17,023.00 |
| Jun 30, 2024 | -12,351.00 |
| Mar 31, 2024 | -1.27 Mn |
| Dec 31, 2023 | -348,676.00 |
| Sep 30, 2023 | 16,508.00 |
| Jun 30, 2023 | 54,652.00 |
| Mar 31, 2023 | 369,429.00 |
| Dec 31, 2022 | 722,710.00 |
| Sep 30, 2022 | -3.69 Mn |
| Jun 30, 2022 | -867,937.00 |
| Mar 31, 2022 | 3.85 Mn |
| Dec 31, 2021 | -8.03 Mn |
| Sep 30, 2021 | -312,679.00 |
API Access
Ensysce Biosciences Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();